Université Paris-Saclay and its partners at Viva Technology 2025

•  Augur, this start-up was co-founded by three Université Paris-Saclay alumni, Emmanuel Menier, Matthieu Nastorg and Christophe Nourissier. It originated from the Interdisciplinary Laboratory of Numerical Sciences (Lisn - Univ. Paris-Saclay/Inria/CNRS/CentraleSupélec). It develops artificial intelligence models to optimise industrial design processes, with a particular focus on improving digital simulation tools.

•    Entalpic was co-founded by Alexandre Duval, a CentraleSupélec alumnus, Victor Schmidt and Mathieu Galtier, and resulted from research conducted at the Centre for Visual Computing (CVN - Univ. Paris-Saclay/CentraleSupélec/Inria). It specialises in materials discovery using artificial intelligence, dedicated to the development of smarter, more sustainable industrial processes. It focuses on the discovery of innovative catalysts capable of optimising chemical reactions, thereby significantly reducing CO₂ emissions in energy-intensive industries. Its technology is based on a state-of-the-art generative AI platform that generates candidate materials and their synthesis routes, with tailored physical-chemical properties and constraints.

•    MaasiRNA is a start-up resulting from research at the Metabolic and Systemic Aspects of Oncogenesis for New Therapeutic Approaches laboratory (Mesty -Univ. Paris-Saclay/CNRS/Gustave Roussy) and the Diseases and Hormones of the Nervous System laboratory (DHNS - Univ. Paris-Saclay/Inserm). It was founded in January 2024 by Liliane Massade, a CNRS research director. Pioneering a new technology platform, SHARK® II, it specifically targets siRNAs for nervous system diseases with major medical needs.

•    Mihaly, this start-up was co-founded by Christophe Leynadier and Jean-Marie Campiglia. It develops 3D colour scanning and printing technology for luxury, culture and material reproduction. It was supported by the Institut d'Optique Graduate School's (IOGS) innovation-entrepreneurship programme (FIE) and is based at the IOGS 503 entrepreneurial centre.

•    Nellow, originating from a collaboration between the Albert Fert Laboratory (LAF - Univ. Paris-Saclay/CNRS/Thales) and the Spintronics and Technology of Components Laboratory (Spintec - Univ. Grenoble Alpes/CNRS/CEA), was co-founded by two LAF researchers, Laurent Villa and Manuel Bibes, and a researcher from Spintec, Jean-Philippe Attané. It targets the microelectronic logic market in memory devices, through the invention of a new type of ultra-low power technology.

•    Synaptys, co-founded by Sébastien Lasnier, is a biotech start-up developing a new therapeutic approach that could transform the lives of patients affected by Alzheimer's disease. It was incubated by IncubAlliance, the public research incubator for the Paris-Saclay area.
 

•  Debecom is a start-up resulting from research carried out at the Supélec ONERA DSTA Research Alliance laboratory (Sondra - Univ. Paris-Saclay/ONERA/CentraleSupélec/DSO National Laboratories/National University of Singapore) and was founded by Laurent Fournier. This telecoms services company is developing and industrialising the DjeeBox solution, designed to provide ultra-high-speed broadband for all, even in locations where fibre is unavailable. DjeeBox is a "Plug and Play" box that can be positioned on windows to pick up the 4G/5G signal and "reinject" it inside a building with Wi-Fi, using an innovative, patented technological process.

•    Exeliom Biosciences emerged from research conducted at the Microbiology of Human Health Laboratory (Micalis - Univ. Paris-Saclay/AgroParisTech/INRAE). The start-up was co-founded by Philippe Langella, INRAE research director, Benjamin Hadida, Harry Sokol and Patrick Gervais. This clinical-stage biotech develops microbiome-derived drugs to improve treatments for cancer and chronic inflammatory bowel disease (IBD).

•    Kalysta Actuation from the SEHA maturation project, supported by SATT Paris-Saclay and the research work of the Versailles Systems Engineering Laboratory (Lisv - Univ. Paris-Saclay/UVSQ) and the Computer Science, Bioinformatics and Complex Systems Laboratory (Ibisc - Univ Paris-Saclay/Univ. Évry Paris-Saclay). The start-up was founded by Université Évry Paris-Saclay academic Samer Alfayad. It develops ultra-compact electrohydraulic components with high strength-to-weight ratios for robotics and embedded systems, controlled via EtherCAT/ROS2.

•    LumiSync emerged from research at the Centre for Nanoscience and Nanotechnology (C2N - Univ. Paris-Saclay/CNRS/Univ. Paris-Cité) and was co-founded by Giuseppe Modica, a former CNRS researcher, and Alexis Jonville. It has developed the world's first 100% photonic oscillator, enabling data centres to continue increasing their data processing throughput, while considerably reducing their energy consumption.

•    Raidium was co-founded by Pierre Manceron, an alumnus of CentraleSupélec and ENS Paris-Saclay, Paul Hérent and Sebastian Schwarz. It is developing the first multimodal 3D foundation model for precision radiology, delivered to radiologists in a radiology console incorporating interactive AI. The first use cases target oncology clinical trial biomarkers, paving the way for integration across the full radiology workflow.

•    Ublo was co-founded by Agathe Machavoine, an alumna of ENS Paris-Saclay, and Flavien Douetteau and is currently revolutionising rental management. Using a SaaS platform, it automates property managers' tasks, streamlines communication and optimises asset management.

•    E-miRgency emerged from research at the Centre for Nanoscience and Nanotechnology (C2N - Univ. Paris-Saclay/CNRS/Univ. Paris-Cité) and was co-founded by Olivier Lavergne, a Université Paris-Saclay alumnus, and Marie Charlotte Horny. The start-up has developed an in vitro diagnostic medical device for the direct detection and assay of circulating microRNAs, enabling their use as biomarkers in cancer diagnosis and monitoring.

•    Exwayz is a start-up co-founded by Hassan Bouchiba, Antoine Plat and Mathias Corsia, and is currently revolutionising autonomous vehicle navigation with Exwayz SLAM, a proprietary simultaneous localisation and mapping algorithm based on 3D LiDAR data. This advanced technology provides virtual trajectory tracking with centimetre accuracy, enhancing safety, reliability and precision. This start-up is incubated at 21st by CentraleSupélec.

•    Iris Lab, a start-up co-founded by Bastien Fabre, Lakshman Srinivasan and Nicolas Bourliatoux, is developing a long-distance, wireless laser power transmission technology for robotics. It is based at 503, the IOGS entrepreneurial centre.

•    Micro Xpace is the result of research carried out at the Molecular Biology and Parasitic Immunology Laboratory (Bipar - INARE/Anses/ENVA). Co-founded by INRAE researchers Alexandro Cabezas-Cruz and Luis Bermudez, alongside Astrid Holzer, Dasiel Obregon, Camille Chauvin and Maykel Andres Galloso-Hernandez, the start-up develops microbial animal health solutions aimed at reducing infectious diseases and supporting sustainable agriculture.

•    QAP Computing is the result of research carried out at the Formal Methods Laboratory (LMF - Univ. Paris-Saclay/Inria/CNRS/ENS Paris-Saclay/CentraleSupélec) and was co-founded by Marc Baboulin, a lecturer at Université Paris-Saclay, Benoit Valiron, a lecturer at CentraleSupélec and Brice Pointal, an Inria engineer. This quantum software start-up uses the exponential capabilities of quantum computing to accelerate high-performance computing and data analysis applications.

•    Quantstack is a start-up founded by Sylvain Corlay, an alumnus of ENS Paris-Saclay. It publishes open-source software and specialises in scientific computing. It is responsible for the development of projects adopted by millions of users worldwide, such as Jupyter, conda-forge and Apache Arrow.

•    Detera Therapeutics is a start-up that emerged from research carried out at the Chemical Biology Laboratory of the Department of Medicines and Technologies for Health (MTS - Univ. Paris-Saclay/INRAE/CEA). It was co-founded by Daniel Gillet, a CEA research director, Pierre-Louis Tharaux, nephrologist at Inserm, and Lyse Santoro. It develops disruptive therapies for rare kidney diseases, with an initial first-in-class candidate, the biomedicine DTR8, which specifically targets crescentic glomerulonephritis (CNG). Unlike current immunosuppressants, DTR8 acts locally and specifically to halt renal deterioration and preserve kidney function. The first human study is planned within the next two years.

•    GreenFusyon emerged from research at the Paris-Saclay Food and Bioproduct Engineering Laboratory (Sayfood - Univ. Paris-Saclay/AgroParisTech/INRAE) and the Process and Materials Engineering Laboratory (LGPM - Univ. Paris-Saclay/CentraleSupélec). The start-up was co-founded by Jacques de Montigny, an alumnus of AgroParisTech, and Stanislas Randon. It uses by-products from biogas plants to produce chlorella, a microalga rich in omega-3, proteins and B12 vitamins, which is sold to the food industry.

•    Nodia Metabolics is a start-up resulting from research conducted at the Microbiology of Human Health Laboratory (Micalis - Univ. Paris-Saclay/AgroParisTech/INRAE). It was co-founded by INRAE researchers Christine Delorme, Vincent Juillard, Séverine Layec and Véronique Douard. It develops natural active ingredients to combat prediabetes, with promising preclinical results.